Skip to main content

Table 1 Demographic characteristics of HIV-infected adults after 12 years of suppressive cART and age-and-gender-matched healthy HIV-negative counterparts from the same community

From: Innate lymphoid cell dysfunction during long-term suppressive antiretroviral therapy in an African cohort

Characteristics

Optimal respondersa

N = 17

Healthy HIV-negative

N = 17

Age [median (IQR)], years

47 (41, 62)

45 (35,62)

Female gender n (%)

13 (76.4)

12 (70.5)

Baseline CD4 count: median (IQR) cells/µl

97 (11, 158)

N/A

Current CD4: median (IQR) cells/µl

898 (796, 1587)

N/A

BMI; median (IQR)

22.57 (20,25)

25.95 (22, 30)

cART duration in years median (IQR)

13.4 (12.8, 14.2)

N/A

Hypertension (%)

1 (5.8)

1 (5.8)

Diabetes (%)

1 (5.8)

0 (0.0)

Fever

0

0

Current regimen

  

ZDV-3TC-NVP (%)

6.0

N/A

ZDV-3TC-EFV (%)

17.0

N/A

TDF-3TC-EFV (%)

6.0

N/A

TDF-3TC-DTG (%)

71

N/A

  1. aAll optimal responders started cART at CD4 counts < 200 cell/µl and had sustained viral suppression from the first viral load test after six months of cART
  2. IQR, Interquartile range; ZDV, zidovudine; 3TC, lamivudine; NVP, nevirapine; EFV, efavirenz